Holen Sie sich die Stockscreener-App
7.23
1.83%
0.13
Schlusskurs vom Vortag:
$7.10
Offen:
$7.15
24-Stunden-Volumen:
1.02M
Relative Volume:
3.06
Marktkapitalisierung:
$200.63M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+29.11%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$6.72
$7.48
1-Wochen-Bereich:
$5.29
$7.48
52-Wochen-Spanne:
$4.68
$7.48
Curanex Pharmaceuticals Inc Stock (CURX) Company Profile
Firmenname
Curanex Pharmaceuticals Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CURX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CURX
Curanex Pharmaceuticals Inc
|
7.23 | 197.03M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Curanex Pharmaceuticals Inc Aktie (CURX) Neueste Nachrichten
Chinese Stocks To Watch Today – September 2nd - Defense World
Chinese Stocks To Watch Today – August 31st - Defense World
Chinese Stocks To Watch TodayAugust 31st - MarketBeat
Curanex Pharmaceuticals announces pricing of its initial public offering - MSN
Promising Chinese Stocks To ConsiderAugust 30th - MarketBeat
Chinese Stocks To Research – August 29th - Defense World
Wall Street Zen Upgrades Curanex Pharmaceuticals (NASDAQ:CURX) to “Hold” - Defense World
Curanex Pharmaceuticals (NASDAQ:CURX) Raised to “Hold” at Wall Street Zen - Defense World
IPO NewsUS IPO Weekly Recap: Quiet week as IPO market gears up for a busy fall - renaissancecapital.com
Curanex Pharmaceuticals closes $15 million IPO on NASDAQ - Investing.com
Curanex Pharmaceuticals Inc. (CURX) Soars 10.52% on Successful IPO - AInvest
Curanex Pharmaceuticals shares rise 7.30% premarket after closing its initial public offering of 3,750,000 shares at $4.00 per share. - AInvest
Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering - GlobeNewswire
Curanex Pharmaceuticals' IPO: A Strategic Bet on Botanical Innovation in a Resilient Biotech Sector - AInvest
Curanex Pharmaceuticals closes $15 million IPO on NASDAQ By Investing.com - Investing.com Canada
Curanex Pharmaceuticals Inc. announces closing of its initial public offering - MarketScreener
Curanex Pharmaceuticals Completes Initial Public Offering for $15 Million - AInvest
$15 Million IPO: Inflammatory Disease Biotech Curanex Launches on Nasdaq with Botanical Drug Focus - Stock Titan
Curanex Pharmaceuticals Inc(NasdaqCM: CURX) added to NASDAQ Composite Index - MarketScreener
IPO Preview | Curanex Will be Listed on 8/26/2025 - AInvest
Curanex Pharmaceuticals prices IPO at $4 per share - Investing.com
Curanex Pharmaceuticals prices IPO at $4 per share, raises $15 million By Investing.com - Investing.com South Africa
Curanex Pharmaceuticals' Nasdaq Debut: A Cautious Bet on Botanical Innovation - AInvest
Curanex Pharmaceuticals Shares Fall in Nasdaq Debut - MarketScreener
CURX IPO NewsPreclinical biotech Curanex Pharmaceuticals prices IPO at $4, the low end of the range - renaissancecapital.com
Curanex Pharmaceuticals prices IPO at $4 per share, raises $15 million - Investing.com
Curanex Pharmaceuticals prices IPO at $4 per share By Investing.com - Investing.com UK
Curanex pharmaceuticals announces pricing of its initial public offering - MarketScreener
Curanex Pharmaceuticals announces pricing of IPO - AInvest
$15 Million IPO: Botanical Drug Developer Curanex Lists on Nasdaq to Advance Ulcerative Colitis Treatment - Stock Titan
Curanex Pharmaceuticals Plans $10 million IPO for August 26th (CURX) - Defense World
Curanex Pharmaceuticals Files for 3.75M Share IPO at $4-$6/sh - Investing.com Canada
Curanex, botanical drug developer, files for $10M IPO - MSN
Finanzdaten der Curanex Pharmaceuticals Inc-Aktie (CURX)
Es liegen keine Finanzdaten für Curanex Pharmaceuticals Inc (CURX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):